Estimated proportions of persons in care for HIV infection treated according to guidelines, by Ryan White Program funding status King County Washington, southern Louisiana and Michigan, 1998.

RWP: Ryan White Program; HAART: Highly active antiretroviral therapy; PCP: Pneumocystis jirovecii pneumonia; MAC: Mycobacterium avium complex; TB: tuberculosis; CD4: CD4+ T-lymphocyte count in cells/μL; CI: confidence interval.
*Treated/eligible = number of persons receiving care/number of persons eligible for care
†Eligibility for HAART was defined as CD4<500, PCR>20000, bDNA>10000 or AIDS-defining opportunistic illness diagnosis (any time before or during 1998)
‡Eligibility for PCP prophylaxis was defined as CD4<200 or PCP diagnosis (any time before or during 1998)
§p≤.001 for ?2 comparing percentages of patients at RWP and non-RWP funded providers within study site
∥Eligibility for MAC prophylaxis was defined as CD4<50 cells/μL or M. avium complex diagnosis (any tine before or during 1998)
‡‡p≤.05 for ?2 comparing percentages of patients at RWP and non-RWP funded providers within study site
**Eligibility for TB test was defined as follows: no tuberculosis diagnosis or sputum culture positive to M. tuberculosis prior to 1998.
¶p≤.01for ?2 comparing percentages of patients at RWP and non-RWP funded providers within study site
††The only exclusions from this analysis were men, and women with a diagnosis of invasive cervical cancer and age 13–17 with non-sexual transmission mode.